In the present study, we investigated if 17β‐estradiol (E2) treatment is sufficient to inhibit human bone marrow mesenchymal stem cells (HBMMSCs)‐mediated invasive motility activity through impairing IL‐8 function, and further identified the related precise molecular and cellular mechanisms in human gastric cancer cells. The gene discussed is CXCL8; the disease is gastric cancer.